Prescription ID | TCMF3668 |
Pinyin Name | Cui Ru Wan |
Chinese Name | 催乳丸 |
English Name | Cui Ru Pills |
Function Description | 缺乳 |
Indications | Hypogalactia disorder |
Disease ICD-11 Category |
SC12 [Hypogalactia disorder (TM1), 缺乳 (TM1)
]; |
Human Tissues Associated with Indication | |
Reference | CFDA |
Reference Book/link | http://samr.cfda.gov.cn/WS01/CL0001/ |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH421 | Angelica sinensis | 当归 | TCMH421 | ITSAF173-14 |
TCMH2119 | Tetrapanax papyriferus | 通草 | TCMH2119 | |
TCMH1430 | Hordeum vulgare | 麦芽 | TCMH1430 | ITSAI3101-14 |
TCMH305 | Cnidium officinale | 川芎 | TCMH305 | ITSAP4207-14 |
TCMH293 | Manis pentadactyla | 穿山甲 | TCMH293 | GBMA15413-17 |
TCMH1331 | Rhaponticum uniflorum | 漏芦 | TCMH1331 | ITSAJ4341-14 |
TCMH451 | Rehmannia glutinosa | 地黄 | TCMH451 | ITSAH4578-14 |
TCMH981 | Astragalus membranaceus | 黄芪 | TCMH981 | ITSAK2981-14 |
TCMH1346 | Cornu cervi degelatinatum | 鹿角霜 | TCMH1346 | |
TCMH104 | Paeonia lactiflora | 白芍 | TCMH104 | ITSAH2416-14 |
TCMH1533 | Saussurea lappa | 木香 | TCMH1533 | |
TCMH2161 | Vaccaria segetalis | 王不留行 | TCMH2161 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT102 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | Hydrolase | P24666 |
TCMT103 | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | Hydrolase | P10586 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT139 | CA6 | Carbonic anhydrase VI | Lyase | P23280 |
TCMT140 | CA5B | Carbonic anhydrase VB | Lyase | Q9Y2D0 |
TCMT141 | CA5A | Carbonic anhydrase VA | Lyase | P35218 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT150 | RORC | Nuclear receptor ROR-gamma | Nuclear receptor | P51449 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT161 | HCAR2 | Hydroxycarboxylic acid receptor 2 | GPCR | Q8TDS4 |
TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
TCMT206 | CYP2A6 | Cytochrome P450 2A6 | Oxidoreductase | P11509 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT268 | CYP2A13 | Cytochrome P450 2A13 | Oxidoreductase | Q16696 |
TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT30 | PTGS2 | Cyclooxygenase-2 | Oxidoreductase | P35354 |
TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
TCMT315 | HTR6 | Serotonin 6 (5-HT6) receptor | GPCR | P50406 |
TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
TCMT332 | AOC3 | Amine oxidase, copper containing | Oxidoreductase | Q16853 |
TCMT335 | MPO | Myeloperoxidase | Oxidoreductase | P05164 |
TCMT336 | IDO1 | Indoleamine 2,3-dioxygenase | Oxidoreductase | P14902 |
TCMT560 | F10 | Coagulation factor X | Unclassified | P00742 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
TCMT599 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Transferase | P61088 |
TCMT614 | EGLN1 | Egl nine homolog 1 | Oxidoreductase | Q9GZT9 |
TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
TCMT690 | HDAC3 | Histone deacetylase 3 | Hydrolase | O15379 |
TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT907 | FDPS | Farnesyl diphosphate synthase | Lyase | P14324 |
Target ID | Target Name |
---|---|
TCMT1178 | Actinomyces viscosus |
TCMT1189 | Pseudomonas fluorescens |
TCMT1190 | Plasmodium falciparum (isolate FcB1 / Columbia) |
TCMT1209 | Staphylococcus haemolyticus |
TCMT1210 | Streptococcus sobrinus |
TCMT1211 | Fusobacterium nucleatum |
TCMT1212 | Verticillium dahliae |
TCMT1218 | Staphylococcus aureus |
TCMT1219 | Enterococcus |
TCMT1222 | Plasmodium falciparum D6 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1227 | Streptococcus |
TCMT1229 | Enterococcus faecalis |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1243 | Aspergillus flavus |
TCMT1245 | Phytophthora cactorum |
TCMT1246 | Escherichia coli |
TCMT1251 | Candida albicans |
TCMT1253 | Penicillium chrysogenum |
TCMT1255 | Human immunodeficiency virus 1 |
TCMT1284 | Penicillium expansum |
TCMT1286 | Bacillus cereus |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1321 | Staphylococcus hominis |
TCMT1343 | Staphylococcus simulans |
TCMT1344 | Staphylococcus sciuri |
TCMT1346 | Helicobacter pylori |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1353 | Plasmodium yoelii |
TCMT1361 | Neisseria meningitidis |
TCMT1370 | Prevotella melaninogenica |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1408 | Colletotrichum gloeosporioides |
TCMT1412 | Salmonella typhimurium |
TCMT1438 | Plasmodium falciparum |
TCMT1439 | Mycobacterium smegmatis |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1444 | Fusarium oxysporum |
TCMT1447 | Respiratory syncytial virus |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1458 | Filobasidiella neoformans |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 14.0837 |
[BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 13.1331 |
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, ALOX5, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FDPS, FUT7, IDO1, MPO, PPARA, PTGS2, XDH | 13.1331 |
[BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FABP4, FDPS, FUT7, HSD17B1, PPARA, PTGS2 | 8.12944 |
[BP] GO:0015711 | organic anion transport | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA | 7.54818 |
[BP] GO:0006820 | anion transport | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA | 6.29655 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 6.25467 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 6.10168 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 | 6.08456 |
[BP] GO:0019369 | arachidonic acid metabolic process | CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 | 6.03977 |
[BP] GO:0006690 | icosanoid metabolic process | ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 | 5.93892 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FABP4, FDPS, FUT7, PPARA, PTGS2 | 5.7029 |
[BP] GO:0006631 | fatty acid metabolic process | ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, PTGS2 | 5.3724 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, IDO1, MPO, PTGS2, XDH | 5.09425 |
[BP] GO:1901568 | fatty acid derivative metabolic process | ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 | 4.81531 |
[BP] GO:0009056 | catabolic process | ACHE, ADORA1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, IDO1, MMP1, MMP2, MMP9, MPO, XDH | 4.77938 |
[BP] GO:0032787 | None | ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, IDO1, PPARA, PTGS2 | 4.77938 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FDPS, HSD17B1 | 4.77291 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 | 4.58096 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, IDO1, MMP2, MMP9, MPO, PPARA, PTGS2, RORC | 4.28322 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1, MPO | 4.10924 |
[BP] GO:0009698 | phenylpropanoid metabolic process | CYP1A1, CYP2A13, CYP2A6 | 3.87251 |
[BP] GO:0009804 | coumarin metabolic process | CYP1A1, CYP2A13, CYP2A6 | 3.87251 |
[BP] GO:0008152 | metabolic process | ACHE, ADORA1, AKR1B1, ALOX5, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, F10, FABP3, FABP4, FDPS, FUT7, HSD17B1, IDO1, MMP1, MMP2, MMP9, MPO, PPARA, PTGS2, RORC, XDH | 3.75782 |
[BP] GO:0019216 | regulation of lipid metabolic process | ADORA1, CYP1A1, FABP3, FDPS, HCAR2, PPARA, PTGS2, RORC | 3.58869 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 3.37785 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, ALOX5, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, F10, FABP3, FABP4, FDPS, FUT7, HSD17B1, IDO1, MMP1, MMP2, MPO, PPARA, PTGS2, RORC, XDH | 3.36271 |
[BP] GO:0033993 | response to lipid | CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, FABP3, IDO1, MPO, PTGS2, RORC | 3.27687 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1 | 3.10925 |
[BP] GO:0043436 | oxoacid metabolic process | ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, IDO1, MPO, PPARA, PTGS2 | 3.10737 |
[BP] GO:0006082 | organic acid metabolic process | ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, IDO1, MPO, PPARA, PTGS2 | 3.04107 |
[BP] GO:0044283 | None | AKR1B1, ALOX5, CYP19A1, CYP1A1, FDPS, IDO1, MPO, PTGS2 | 3.04107 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1 | 3.01088 |
[BP] GO:0006805 | xenobiotic metabolic process | CYP1A1, CYP1A2, CYP1B1, CYP2A13, RORC | 2.90829 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, MMP9, PTGS2 | 2.90829 |
[BP] GO:0010033 | response to organic substance | AKR1B1, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, IDO1, MMP2, MPO, PPARA, PTGS2, RORC | 2.87045 |
[BP] GO:0019752 | carboxylic acid metabolic process | ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, IDO1, PPARA, PTGS2 | 2.68055 |
[BP] GO:0006811 | None | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA | 2.66055 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HCAR2, HSD17B1 | 2.63528 |
[BP] GO:0017144 | drug metabolic process | ACHE, AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, IDO1, MPO | 2.52599 |
[BP] GO:0042221 | response to chemical | AKR1B1, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, IDO1, MMP2, MMP9, MPO, PPARA, PTGS2, RORC | 2.43608 |
[BP] GO:0071248 | cellular response to metal ion | CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 | 2.41361 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.41311 |
[BP] GO:0010647 | positive regulation of cell communication | ADORA1, AKR1B1, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, HCAR2, HTR6, MMP9, PTGS2, XDH | 2.41311 |
[BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, FDPS, HSD17B1, PTGS2 | 2.41311 |
[BP] GO:0023056 | positive regulation of signaling | ADORA1, AKR1B1, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, HCAR2, HTR6, MMP9, PTGS2, XDH | 2.40075 |
[BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.3897 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1 | 2.33848 |
[BP] GO:0016042 | lipid catabolic process | ADORA1, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 | 2.32546 |
[BP] GO:0048661 | positive regulation of smooth muscle cell proliferation | AKR1B1, MMP2, MMP9, PTGS2 | 2.31067 |
[BP] GO:0022900 | electron transport chain | AKR1B1, CYP19A1, CYP1A2, IDO1, XDH | 2.28001 |
[BP] GO:0032847 | regulation of cellular pH reduction | CA2, CA7 | 2.18312 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.18312 |
[BP] GO:0071241 | cellular response to inorganic substance | CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 | 2.18312 |
[BP] GO:0042743 | hydrogen peroxide metabolic process | CYP1A1, CYP1A2, MPO | 2.09163 |
[BP] GO:0032228 | regulation of synaptic transmission, GABAergic | ADORA1, CA2, CA7 | 2.0156 |
[BP] GO:1901575 | None | ACHE, ADORA1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, IDO1, XDH | 2.0156 |
[CC] GO:0016323 | basolateral plasma membrane | ADORA1, CA2, CA4, CA9 | 1.08391 |
[CC] GO:0031233 | None | CA4, F10 | 0.984563 |
[CC] GO:0044444 | cytoplasmic part | ACHE, ADORA1, AKR1B1, ALOX5, CA1, CA2, CA4, CA5A, CA5B, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, F10, FABP3, FABP4, FDPS, FUT7, HSD17B1, IDO1, MMP2, MMP9, MPO, PTGS2, XDH | 0.756568 |
[CC] GO:0005789 | endoplasmic reticulum membrane | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 | 0.722351 |
[CC] GO:0032991 | None | CSNK2A1, PTGS2 | 0.790689 |
[MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 19.6826 |
[MF] GO:0046914 | transition metal ion binding | ALOX5, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MMP1, MMP2, MMP9, PPARA, RORC, XDH | 13.5494 |
[MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 13.3198 |
[MF] GO:0016835 | carbon-oxygen lyase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 12.1224 |
[MF] GO:0016829 | lyase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 8.18351 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, IDO1, MPO, PTGS2 | 8.12944 |
[MF] GO:0043169 | cation binding | ACHE, ALOX5, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, F10, FDPS, IDO1, MMP1, MMP2, MMP9, MPO, PPARA, PTGS2, RORC, XDH | 8.12944 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, IDO1, MPO, PTGS2 | 7.92286 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 7.77082 |
[MF] GO:0043167 | ion binding | ACHE, ALOX5, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, F10, FABP3, FABP4, FDPS, HSD17B1, IDO1, MMP1, MMP2, MMP9, MPO, PPARA, PTGS2, RORC, XDH | 7.70191 |
[MF] GO:0046872 | metal ion binding | ALOX5, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, F10, FDPS, IDO1, MMP1, MMP2, MMP9, MPO, PPARA, PTGS2, RORC, XDH | 7.54818 |
[MF] GO:0003824 | catalytic activity | ACHE, ADORA1, AKR1B1, ALOX5, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, F10, FDPS, FUT7, HSD17B1, IDO1, MMP1, MMP2, MMP9, MPO, PTGS2, XDH | 7.21262 |
[MF] GO:0008270 | zinc ion binding | CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, MMP1, MMP2, MMP9, PPARA, RORC | 6.47426 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 | 6.08456 |
[MF] GO:0005506 | iron ion binding | ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH | 6.08456 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, IDO1, MPO, PTGS2, XDH | 6.08456 |
[MF] GO:0048037 | cofactor binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, IDO1, MPO, PTGS2, XDH | 5.83036 |
[MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 | 4.81531 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 | 4.75871 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 4.70371 |
[MF] GO:0008395 | steroid hydroxylase activity | CYP19A1, CYP1A1, CYP2A13, CYP2A6 | 3.52559 |
[MF] GO:0009055 | electron transfer activity | AKR1B1, CYP19A1, CYP1A2, IDO1, XDH | 3.01088 |
[MF] GO:0008389 | None | CYP2A13, CYP2A6 | 2.83386 |
[MF] GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | ALOX5, IDO1, PTGS2 | 2.25473 |
[MF] GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | ALOX5, IDO1, PTGS2 | 2.20994 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA5B, CA5A, CA2, CA4, CA7, CA6, CA9, CA14 | 21.475 |
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, HSD17B1, CYP1A1, CYP1B1, PTGS2, CYP19A1 | 7.6755 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | CYP2A6, CYP2A13, CYP1A2, CYP1A1, CYP1B1, PTGS2 | 6.5281 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD17B1, CYP1A2, CYP1A1, CYP1B1, CYP19A1 | 5.8496 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | CYP2A6, CYP2A13, CYP1A2, CYP1A1, CYP1B1 | 5.4224 |
Metabolic pathways_Homo sapiens_hsa01100 | FDPS, CYP2A6, FUT7, ALOX5, HSD17B1, CYP1A2, CYP1A1, AKR1B1, PTGS2, CYP19A1, XDH, IDO1 | 4.6225 |
Tryptophan metabolism_Homo sapiens_hsa00380 | CYP1A2, CYP1A1, CYP1B1, IDO1 | 4.9281 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1, PPARA | 4.0791 |
Bladder cancer_Homo sapiens_hsa05219 | MMP1, MMP2, MMP9 | 3.272 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, ADORA1, PTGS2 | 2.9073 |
cAMP signaling pathway_Homo sapiens_hsa04024 | HCAR2, HTR6, ADORA1, PPARA | 2.4525 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP2A6, CYP1A2, CYP1A1 | 2.7528 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP2A6, CYP1A2, XDH | 5.8807 |
Serotonergic synapse_Homo sapiens_hsa04726 | HTR6, ALOX5, PTGS2 | 2.1596 |
Pathways in cancer_Homo sapiens_hsa05200 | MMP1, MMP2, PTGS2, MMP9 | 1.5072 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | ALOX5, PTGS2 | 1.5305 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | CYP2A6, XDH | 1.7575 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP2A6, CYP1A2 | 1.4889 |
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | HTR6, ADORA3, ADORA1 | 1.2349 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | MMP2, MMP9 | 1.2349 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | CYP1B1, PTGS2, MMP9 | 1.1931 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1, PTGS2 | 1.263 |
TNF signaling pathway_Homo sapiens_hsa04668 | PTGS2, MMP9 | 1.1931 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 2.299 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | ADORA3, ADORA1 | 1.1688 |
Leukocyte transendothelial migration_Homo sapiens_hsa04670 | MMP2, MMP9 | 1.1688 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | ADORA3, ADORA1 | 0.9367 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | MMP9, MPO | 0.8993 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | MMP2, MMP9 | 0.8993 |
VEGF signaling pathway_Homo sapiens_hsa04370 | PTGS2 | 0.6755 |
Gastric acid secretion_Homo sapiens_hsa04971 | CA2 | 0.6653 |
Renin secretion_Homo sapiens_hsa04924 | ADORA1 | 0.6702 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B1 | 0.6784 |
Leishmaniasis_Homo sapiens_hsa05140 | PTGS2 | 0.6653 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.6653 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | MMP2 | 0.6381 |
Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | RORC | 0.6702 |
GnRH signaling pathway_Homo sapiens_hsa04912 | MMP2 | 0.6415 |
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.6415 |
Adherens junction_Homo sapiens_hsa04520 | CSNK2A1 | 0.6653 |
Small cell lung cancer_Homo sapiens_hsa05222 | PTGS2 | 0.6415 |
Bile secretion_Homo sapiens_hsa04976 | CA2 | 0.6653 |
Morphine addiction_Homo sapiens_hsa05032 | ADORA1 | 0.6415 |
Cholinergic synapse_Homo sapiens_hsa04725 | ACHE | 0.6153 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1 | 0.6415 |
Complement and coagulation cascades_Homo sapiens_hsa04610 | F10 | 0.6478 |
Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.6381 |
Insulin resistance_Homo sapiens_hsa04931 | PPARA | 0.6153 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.6415 |
Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | PTGS2 | 0.6381 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.6381 |
Measles_Homo sapiens_hsa05162 | CSNK2A1 | 0.5575 |
Hepatitis C_Homo sapiens_hsa05160 | PPARA | 0.5592 |
Pancreatic secretion_Homo sapiens_hsa04972 | CA2 | 0.6381 |
Toxoplasmosis_Homo sapiens_hsa05145 | ALOX5 | 0.5984 |
Hepatitis B_Homo sapiens_hsa05161 | MMP9 | 0.5502 |
Wnt signaling pathway_Homo sapiens_hsa04310 | CSNK2A1 | 0.5542 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | PPARA | 0.5439 |
Tight junction_Homo sapiens_hsa04530 | CSNK2A1 | 0.5558 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | PTGS2 | 0.5394 |
Influenza A_Homo sapiens_hsa05164 | FDPS | 0.5117 |
Calcium signaling pathway_Homo sapiens_hsa04020 | HTR6 | 0.5095 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1 | 0.4795 |
Purine metabolism_Homo sapiens_hsa00230 | XDH | 0.5117 |
Phagosome_Homo sapiens_hsa04145 | MPO | 0.5429 |
HTLV-I infection_Homo sapiens_hsa05166 | FDPS | 0.4006 |
Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.5053 |
African trypanosomiasis_Homo sapiens_hsa05143 | IDO1 | 0.8732 |
Galactose metabolism_Homo sapiens_hsa00052 | AKR1B1 | 0.8993 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | CYP1A2 | 0.8993 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.8993 |
Circadian rhythm_Homo sapiens_hsa04710 | RORC | 0.8993 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.8993 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B1 | 0.8726 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B1 | 0.8993 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.8993 |
Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | FDPS | 0.9367 |